News Roundup [abridged Versions Appear In The Paper Journal] FDA warns about using antipsychotic drugs for dementia BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7497.922-c (Published 21 April 2005) Cite this as: BMJ 2005;330:922 Article Related content Metrics Responses Peer review Related articles Correction FDA warns about using antipsychotic drugs for dementia Published: 26 May 2005; BMJ 330 doi:10.1136/bmj.330.7502.1258-b See more Generics have a chequered recent history BMJ December 05, 2016, 355 i6527; DOI: https://doi.org/10.1136/bmj.i6527 Pfizer could face large fine over pricing of generic phenytoin BMJ November 28, 2016, 355 i6401; DOI: https://doi.org/10.1136/bmj.i6401 Manufacturers tell FDA why they should be able to promote drugs and devices off label BMJ November 14, 2016, 355 i6098; DOI: https://doi.org/10.1136/bmj.i6098 Dietitians have important role in mental health team, say researchers BMJ November 03, 2016, 355 i5913; DOI: https://doi.org/10.1136/bmj.i5913 Women are unaware of pregnancy risks linked with sodium valproate BMJ October 31, 2016, 355 i5829; DOI: https://doi.org/10.1136/bmj.i5829 Cited by... Psychotropic drugs for the behavioural and psychological symptoms of dementia: no free rideFulltext PDF Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4-year periodFulltext PDF Abstract
